The Patent Finder
ST

Spark Therapeutics, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Nine patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Apr 2028. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Apr 2028
Next term end
9
Patent families

When these terms end

Each bar runs from grant to computed term end. 2012 to 2043.
US 8,257,969 Genetic Suppression and Replacement Apr 14, 2028
US 11,168,124 CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS Oct 31, 2036
US 10,633,689 Rab Escort Protein Potency Assay Jan 12, 2038
US 12,404,526 ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION Jun 6, 2038
US 12,359,239 Relative Potency Assay for Viral Vector Encoding Isomerohydrolases May 3, 2039
US 11,702,639 COLUMN-BASED FULLY SCALABLE rAAV MANUFACTURING PROCESS Sep 2, 2040
US 12,084,693 Codon-Optimized Acid Alpha-Glucosidase Expression Cassettes and Methods of Using Same Nov 20, 2041
US 12,290,574 Optimized Promoter Sequences, Intron-Free Expression Constructs and Methods of Use May 4, 2042
US 12,799,501 Plasmid Free Aav Vector Producing Cell Lines Jan 13, 2043
201820242030203620422043
30 pending applications: term is not computable until grant.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 18, 2027
    The maintenance fee for COLUMN-BASED FULLY SCALABLE rAAV MANUFACTURING PROCESS (US 11,702,639) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
  • 1 fee due Oct 28, 2027
    The maintenance fee for Rab Escort Protein Potency Assay (US 10,633,689) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 19, 2026

What they patent

The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 9 of 9

PatentTitleStatusExpiresConfidence
US 8,257,969Genetic Suppression and Replacement
In force
 · High confidence
In forceHigh confidence
US 11,168,124CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS
In force
 · High confidence
In forceHigh confidence
US 10,633,689Rab Escort Protein Potency Assay
In force
 · High confidence
In forceHigh confidence
US 12,404,526ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION
In force
 · High confidence
In forceHigh confidence
US 12,359,239Relative Potency Assay for Viral Vector Encoding Isomerohydrolases
In force
 · High confidence
In forceHigh confidence
US 11,702,639COLUMN-BASED FULLY SCALABLE rAAV MANUFACTURING PROCESS
In force
 · High confidence
In forceHigh confidence
US 12,084,693Codon-Optimized Acid Alpha-Glucosidase Expression Cassettes and Methods of Using Same
In force
 · High confidence
In forceHigh confidence
US 12,290,574Optimized Promoter Sequences, Intron-Free Expression Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 12,799,501Plasmid Free Aav Vector Producing Cell Lines
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 1 patent ended · 30 applications pending · 18 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited